Clinical Trial Update: Paclitaxel, Carboplatin and Vorinostat for the Treatment of Advanced Stage Ovarian Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial of paclitaxel, carboplatin, and vorinostat for advanced ovarian cancer was terminated; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• Vorinostat (vorinostat)

Snippet

Sponsor: Gynecologic Oncology Associates | Conditions: Ovarian Neoplasms | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2017-04-10